UNSPSC 51434962: Atorvastatin/Acetylsalicylic acid/Ramipril

Atorvastatin, Aspirin and Ramipril, which prevents heart attack and stroke. Atorvastatin is a lipid-lowering medication that blocks an enzyme required in the body to make cholesterol.

UNSPSC 51434962 Atorvastatin/Acetylsalicylic acid/Ramipril is a Commodity code that represents specific combination pharmaceutical products, but the recent state and local opportunities record shows minimal relevant procurement activity for this code. Of the sixteen records indexed under this code, only two solicitations—the Seminole County naloxone procurement (IFB60459723LAS, due July 26, 2023) and the City of Tucson Fire Department BLS/ALS pharmaceuticals and supplies RFP (260305, due June 24, 2026)—involve pharmaceutical products at all, and neither directly targets the atorvastatin/acetylsalicylic acid/ramipril combination. The remaining records consist of vendor networking events, county administrative notices, grant forums, forensic drug-standards procurement, employee health clinic services, engineering services, pharmacy network qualifications, generic multi-source pharmaceutical cooperative purchasing, and vendor surveys—none of which align with state or local government purchase of branded or generic cardiovascular combination medications. The Tucson Fire Department solicitation encompasses broad BLS and ALS pharmaceuticals alongside medical supply equipment and software services for emergency medical care, but does not isolate the specific three-drug combination this code nominates. Cooperative purchasing vehicles for generic pharmaceuticals, such as the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP (S1070000015802, due March 26, 2026), address multi-source generic drugs in aggregate but do not list the atorvastatin/acetylsalicylic acid/ramipril combination explicitly in the available scope summary.

State and local governments procuring pharmaceuticals in the recent record do so primarily through emergency medical services (fire/EMS procurement), public health initiatives (Seminole County naloxone procurement for overdose response), and employee health programs (Collier County clinic and wellness services RFP 25-8397). Geographic activity appears concentrated in Florida (Seminole County, Pinellas County, Collier County, Indian River County) and Arizona (Tucson), with national-scope cooperative purchasing through MMCAP administered by Minnesota. The code shows insufficient dedicated procurement volume to support a reliable market characterization; opportunities tagged to this Commodity code appear mislabeled relative to actual buying patterns. Firms pursuing state and local pharmaceutical contracting should focus on emergency medical supply, public health disease-prevention programs, and cooperative purchasing frameworks for generic drugs rather than expecting procurement specifically targeting this branded or narrow-indication combination product.